NEW YORK (Reuters Health) May 24 – Sleep apnea may play an important pathogenic role in some patients with nonarteritic anterior ischemic optic neuropathy (NAION),
NEW YORK (Reuters Health) May 28 – Topical mitomycin C appears to be a safe and effective treatment for conjunctival or corneal squamous cell carcinoma
ORT LAUDERDALE, FL — May 8, 2002 — Switching to Xalatan® (latanoprost ophthalmic solution) once daily from monotherapy with other medications, including prostaglandin derivatives, for
FORT LAUDERDALE, FL — May 8, 2002 — Xalacom® (fixed combination latanoprost 0.005% and timolol 0.5%) once-daily is more effective for the reduction of intraocular
NEW YORK (MedscapeWire) May 16 Microvascular disease may predict subsequent development of type 2 diabetes mellitus even in patients thought to be at low
NEW YORK (Reuters Health) May 20 – Reading a large number of books per week may increase the risk of developing higher myopia, according to
05/17/2002 By Mark Moran Orbital radiotherapy alone appears to be ineffective in treating restrictive thyroid myopathy and improving binocular function, say British researchers. A retrospective
05/10/2002 By Mark Moran Calculating the intraoperative lens power for cataract surgery after photorefractive keratectomy (PRK) can be improved by using a corrected, refraction-derived keratometric
Laurie Barclay, MD NEW YORK (MedscapeWire) May 13 Goniotomy is useful for treating refractory glaucoma linked to chronic uveitis, according to the results of
PEAPACK, NJ — May 1, 2002 — Data presented for the first time at the XXIXth International Congress of Ophthalmology in Sydney, Australia, show that
NEW YORK (Reuters Health) Apr 29 – Treatment with eye drops containing 5-fluorocytosine (5-FC) and cytosine deaminase, the enzyme that converts 5-FC to 5-fluorouracil (5-FU),
NEW YORK (Reuters Health) Apr 29 – Translocation of the retina appears to be a promising therapeutic option for stabilizing or improving vision in patients
Laurie Barclay, MD NEW YORK (MedscapeWire) Apr 26 The antisense oligonucleotide fomivirsen is reasonably safe and effective in treating CMV retinitis in AIDS patients,
NEW YORK (Reuters Health) Apr 22 – Granulocyte colony-stimulating factor therapy in patients with AIDS-related cytomegalovirus (CMV) retinitis is associated with a 56% reduction in
Journal of Glaucoma 04/26/2002 By Mark Moran Brimonidine-purite 0.15% and 0.2%, appears to decrease intraocular pressure comparably to brimonidine 0.2% in patients with glaucoma or
PEAPACK, NJ — April 23, 2002 — Pharmacia Corporation announced today that the company has successfully completed the Mutual Recognition Process in Europe for the
DENVER (Reuters Health) Apr 18 – Implantation of human retinal cells in the brains of patients with Parkinson's disease was safe and well-tolerated in a
NEW YORK (Reuters Health) Apr 17 – The US Food and Drug Administration (FDA) has approved conductive keratoplasty as a procedure for treating hyperopia up
Journal of Glaucoma 04/11/2002 By Mark Moran Both latanoprost and brimonidine reduced intraocular pressure in patients with glaucoma or ocular hypertension after six months of
New England Journal of Medicine (NEJM) 04/11/2002 By Anne MacLennan Oral valganciclovir appears to be as effective as intravenous ganciclovir for induction treatment in cytomegalovirus